Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

about

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

Item

http://www.wikidata.org/entity/Q39295421

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

@en

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

@nl

type

Item

label

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

@en

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

@nl

prefLabel

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

@en

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

@nl

P1476

Calprotectin as a Biomarker for Melioidosis Disease Progression and Management

@en

P2093

Aruna Dharshan De Silva

http://www.w3.org/2001/XMLSchema#string

Beverly K Dyas

http://www.w3.org/2001/XMLSchema#string

Harindra Darshana Sathkumara

http://www.w3.org/2001/XMLSchema#string

Jennifer L Dankmeyer

http://www.w3.org/2001/XMLSchema#string

Kei Amemiya

http://www.w3.org/2001/XMLSchema#string

Robert G Ulrich

http://www.w3.org/2001/XMLSchema#string

Shivankari Krishnananthasivam

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing incidence of human melioidosis in Northeast Thailand

Fecal calprotectin in inflammatory bowel disease

Procalcitonin to guide antibiotic therapy in the ICU

Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis

Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate.

The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study

Treatment and prophylaxis of melioidosis

C-reactive protein: a valuable marker of sepsis.

Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock

Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm

P304

1205-1210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.02284-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Enoka M Corea

Mohan Natesan

P577

2017-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28179407

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

melioidosis

P932

5377848

http://www.w3.org/2001/XMLSchema#string